Encorafenib plus Binimetinib in Patients with locally advanced, non-resectable or metastatic BRAF(V600) mutated Melanoma: first Data from the multicenter, multinational, prospective, non-interventional Longitudinal Study BERING(MELANOMA)

Richtig, E. and Gutzmer, R. and Loquai, C. and Utikal, J. S. and Hoeller, C. and Stadler, R. and Forschner, A. and Hassel, J. C. and Debus, D. and Göppner, D. and Fluck, M. and Haferkamp, S. and Kaatz, M. and Welslau, M. and Dummer, R. and von Moos, R. and Schmidt, A. and Milde, L. and Michielin, O. and Schadendorf, D. (2021) Encorafenib plus Binimetinib in Patients with locally advanced, non-resectable or metastatic BRAF(V600) mutated Melanoma: first Data from the multicenter, multinational, prospective, non-interventional Longitudinal Study BERING(MELANOMA). In: 31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, hybrid.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Petra Gürster
Date Deposited: 13 Dec 2022 07:17
Last Modified: 13 Dec 2022 07:17
URI: https://pred.uni-regensburg.de/id/eprint/47961

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.